Davis Jerel, Director at CHINOOK THERAPEUTICS, INC. (KDNY), sold 295,808 shares at $20.75 ($6.1M) on 2023-04-17, disclosed to the SEC on 2023-04-19.
Open-market sale of $6.1M KDNY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RPTX | SELL | 2022-12-13 | $4.0M | — | Filing → |
| RPTX | SELL | 2022-06-07 | $15.3M | — | Filing → |
| KDNY | SELL | 2022-01-05 | $16.0M | — | Filing → |